Genetic Property Plant Equipment vs Total Assets Analysis

GTG Stock   0.04  0.00  0.00%   
Genetic Technologies financial indicator trend analysis is much more than just examining Genetic Technologies latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genetic Technologies is a good investment. Please check the relationship between Genetic Technologies Property Plant Equipment and its Total Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Genetic Stock please use our How to Invest in Genetic Technologies guide.

Property Plant Equipment vs Total Assets

Property Plant Equipment vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genetic Technologies Property Plant Equipment account and Total Assets. At this time, the significance of the direction appears to have very week relationship.
The correlation between Genetic Technologies' Property Plant Equipment and Total Assets is 0.22. Overlapping area represents the amount of variation of Property Plant Equipment that can explain the historical movement of Total Assets in the same time period over historical financial statements of Genetic Technologies, assuming nothing else is changed. The correlation between historical values of Genetic Technologies' Property Plant Equipment and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant Equipment of Genetic Technologies are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Property Plant Equipment i.e., Genetic Technologies' Property Plant Equipment and Total Assets go up and down completely randomly.

Correlation Coefficient

0.22
Relationship DirectionPositive 
Relationship StrengthVery Weak

Property Plant Equipment

Total Assets

Total assets refers to the total amount of Genetic Technologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Genetic Technologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Genetic Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genetic Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Genetic Stock please use our How to Invest in Genetic Technologies guide.At this time, Genetic Technologies' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is expected to grow at the current pace this year, whereas Issuance Of Capital Stock is likely to drop slightly above 2.4 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses3.1M18.1M3.9M3.7M
Cost Of Revenue321.2K4.3M3.8M3.9M

Genetic Technologies fundamental ratios Correlations

0.05-0.140.980.81-0.9-0.09-0.20.90.2-0.590.90.090.28-0.16-0.1-0.42-0.080.430.940.320.22-0.4-0.03-0.08-0.35
0.050.36-0.060.350.220.080.31-0.190.45-0.11-0.180.24-0.070.160.21-0.140.640.35-0.12-0.020.280.620.09-0.010.07
-0.140.36-0.310.130.41-0.550.84-0.380.46-0.06-0.380.820.22-0.18-0.19-0.520.730.71-0.310.320.240.22-0.350.10.83
0.98-0.06-0.310.73-0.940.0-0.360.930.11-0.550.93-0.060.23-0.1-0.05-0.32-0.260.290.950.260.18-0.490.05-0.09-0.46
0.810.350.130.73-0.55-0.070.120.570.56-0.640.570.290.18-0.1-0.07-0.450.280.620.620.250.38-0.09-0.11-0.11-0.25
-0.90.220.41-0.94-0.550.160.47-1.00.210.47-1.00.13-0.40.320.260.240.37-0.15-0.98-0.40.070.490.070.040.47
-0.090.08-0.550.0-0.070.16-0.37-0.180.220.24-0.18-0.5-0.860.750.710.54-0.33-0.59-0.17-0.910.350.080.59-0.38-0.56
-0.20.310.84-0.360.120.47-0.37-0.440.51-0.04-0.440.70.25-0.18-0.18-0.260.830.58-0.390.280.080.26-0.380.010.61
0.9-0.19-0.380.930.57-1.0-0.18-0.44-0.21-0.481.0-0.090.42-0.35-0.28-0.26-0.30.170.990.42-0.08-0.45-0.1-0.04-0.45
0.20.450.460.110.560.210.220.51-0.21-0.39-0.210.3-0.280.290.21-0.190.420.46-0.15-0.20.480.18-0.05-0.120.09
-0.59-0.11-0.06-0.55-0.640.470.24-0.04-0.48-0.39-0.48-0.17-0.330.370.430.45-0.15-0.45-0.46-0.390.12-0.110.470.050.19
0.9-0.18-0.380.930.57-1.0-0.18-0.441.0-0.21-0.48-0.090.42-0.35-0.28-0.26-0.30.170.990.42-0.08-0.44-0.1-0.04-0.45
0.090.240.82-0.060.290.13-0.50.7-0.090.3-0.17-0.090.24-0.18-0.16-0.630.590.67-0.010.320.350.08-0.26-0.350.71
0.28-0.070.220.230.18-0.4-0.860.250.42-0.28-0.330.420.24-0.8-0.73-0.360.260.480.380.98-0.53-0.11-0.570.350.2
-0.160.16-0.18-0.1-0.10.320.75-0.18-0.350.290.37-0.35-0.18-0.80.980.06-0.24-0.18-0.26-0.770.75-0.150.88-0.26-0.07
-0.10.21-0.19-0.05-0.070.260.71-0.18-0.280.210.43-0.28-0.16-0.730.980.04-0.19-0.14-0.17-0.70.76-0.20.94-0.21-0.1
-0.42-0.14-0.52-0.32-0.450.240.54-0.26-0.26-0.190.45-0.26-0.63-0.360.060.04-0.31-0.84-0.35-0.49-0.430.170.04-0.07-0.53
-0.080.640.73-0.260.280.37-0.330.83-0.30.42-0.15-0.30.590.26-0.24-0.19-0.310.6-0.250.310.050.56-0.380.130.43
0.430.350.710.290.62-0.15-0.590.580.170.46-0.450.170.670.48-0.18-0.14-0.840.60.270.610.36-0.1-0.190.210.47
0.94-0.12-0.310.950.62-0.98-0.17-0.390.99-0.15-0.460.99-0.010.38-0.26-0.17-0.35-0.250.270.40.06-0.49-0.01-0.04-0.39
0.32-0.020.320.260.25-0.4-0.910.280.42-0.2-0.390.420.320.98-0.77-0.7-0.490.310.610.4-0.42-0.13-0.550.40.26
0.220.280.240.180.380.070.350.08-0.080.480.12-0.080.35-0.530.750.76-0.430.050.360.06-0.42-0.250.66-0.30.19
-0.40.620.22-0.49-0.090.490.080.26-0.450.18-0.11-0.440.08-0.11-0.15-0.20.170.56-0.1-0.49-0.13-0.25-0.38-0.070.1
-0.030.09-0.350.05-0.110.070.59-0.38-0.1-0.050.47-0.1-0.26-0.570.880.940.04-0.38-0.19-0.01-0.550.66-0.38-0.17-0.19
-0.08-0.010.1-0.09-0.110.04-0.380.01-0.04-0.120.05-0.04-0.350.35-0.26-0.21-0.070.130.21-0.040.4-0.3-0.07-0.170.08
-0.350.070.83-0.46-0.250.47-0.560.61-0.450.090.19-0.450.710.2-0.07-0.1-0.530.430.47-0.390.260.190.1-0.190.08
Click cells to compare fundamentals

Genetic Technologies Account Relationship Matchups

Genetic Technologies fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets15.6M23.0M20.8M14.9M6.2M5.9M
Other Current Liab1.0M955.5K1.6M1.3M1.1M940.6K
Total Current Liabilities1.4M1.4M3.8M3.3M4.2M4.4M
Total Stockholder Equity14.0M21.5M16.4M11.2M1.8M1.7M
Property Plant And Equipment Net440.2K637.7K953.3K599.2K264.5K251.3K
Net Debt(13.7M)(20.7M)(11.1M)(7.3M)(145.4K)(152.7K)
Retained Earnings(136.0M)(143.1M)(150.2M)(156.7M)(166.4M)(158.1M)
Accounts Payable350.2K269.7K1.2M838.0K1.5M851.7K
Cash14.2M20.9M11.7M7.9M1.0M969.6K
Non Current Assets Total440.2K735.6K6.1M4.2M2.5M2.4M
Non Currrent Assets Other(440.2K)(9.5M)(6.1M)(4.2M)81.7K85.8K
Cash And Short Term Investments14.2M20.9M11.7M7.9M1.0M969.6K
Net Receivables38.9K1.1M2.4M191.9K2.1M2.2M
Common Stock Shares Outstanding41.6M85.4M92.2M101.4M138.4M263.3M
Liabilities And Stockholders Equity15.6M23.0M20.8M14.9M6.2M5.9M
Inventory91.4K76.9K398.2K325.9K206.5K196.1K
Other Stockholder Equity1.2M(10.5M)(4.9M)(4.6M)(4.2M)(4.0M)
Total Liab1.6M1.4M4.4M3.7M4.4M2.3M
Property Plant And Equipment Gross440.2K1.3M1.9M1.8M1.5M946.1K
Total Current Assets15.2M22.2M14.7M10.5M3.7M3.5M
Common Stock140.1M153.6M155.1M161.3M163.8M99.3M
Property Plant Equipment440.2K637.7K953.3K599.2K539.3K876.6K
Other Current Assets846.3K182.6K18.2K2.1M341.7K390.1K
Short Term Investments2.0K1.9K13.3K17.4K18.8K17.9K
Non Current Liabilities Total52.3K33.3K558.9K381.6K160.6K152.6K
Accumulated Other Comprehensive Income8.8M11.0M11.5M6.5M4.4M4.3M
Other Liab979.2K8.9K170.5K152.3K175.2K133.1K
Net Tangible Assets13.0M21.5M11.3M7.5M8.7M11.1M
Long Term Debt Total240.9K24.4K388.4K229.3K263.7K138.8K
Net Invested Capital13.1M21.5M16.4M11.2M2.5M2.4M
Net Working Capital13.8M20.8M10.9M7.2M(500.1K)(475.1K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Genetic Stock Analysis

When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.